Multiple sclerosis relapse and Cognitive disorder

Summary:

Cognitive disorder is found among people with Multiple sclerosis relapse, especially for people who are female, 50-59 old.

The study analyzes which people have Cognitive disorder with Multiple sclerosis relapse. It is created by eHealthMe based on reports of 58 people who have Multiple sclerosis relapse from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,033 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.

What is Cognitive disorder?

Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving) is found to be associated with 1,649 drugs and 1,727 conditions by eHealthMe. Check the latest studies of Cognitive disorder.



On Jul, 29, 2026

58 people who have Multiple Sclerosis Relapse and Cognitive Disorder are studied.

Would you have Cognitive disorder when you have Multiple sclerosis relapse?

Gender of people who have Multiple Sclerosis Relapse and experienced Cognitive Disorder *:

  • female: 81.03 %
  • male: 18.97 %

Age of people who have Multiple Sclerosis Relapse and experienced Cognitive Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 1.82 %
  • 20-29: 9.09 %
  • 30-39: 30.91 %
  • 40-49: 16.36 %
  • 50-59: 32.73 %
  • 60+: 9.09 %

Common co-existing conditions for these people *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 19 people, 32.76%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 20.69%
  3. Pain: 9 people, 15.52%
  4. Depression: 6 people, 10.34%
  5. Afterbirth Pain: 5 people, 8.62%
  6. Anaemia (lack of blood): 5 people, 8.62%
  7. Birth Control: 5 people, 8.62%
  8. Constipation: 5 people, 8.62%
  9. Rickets (softening of bones): 5 people, 8.62%
  10. High Blood Pressure: 4 people, 6.90%

Common drugs taken by these people *:

  1. Gilenya: 25 people, 43.10%
  2. Solu-Medrol: 13 people, 22.41%
  3. Tysabri: 8 people, 13.79%
  4. Benadryl: 7 people, 12.07%
  5. Prozac: 6 people, 10.34%
  6. Ampyra: 6 people, 10.34%
  7. Maxalt: 6 people, 10.34%
  8. Vitamin D2: 5 people, 8.62%
  9. Oxycodone: 5 people, 8.62%
  10. Advil: 5 people, 8.62%

Common symptoms for these people *:

  1. Memory Loss: 19 people, 32.76%
  2. Visual Impairment: 18 people, 31.03%
  3. Weakness: 17 people, 29.31%
  4. Back Pain: 16 people, 27.59%
  5. Fatigue (feeling of tiredness): 15 people, 25.86%
  6. Headache (pain in head): 15 people, 25.86%
  7. Pain: 13 people, 22.41%
  8. Gait Disturbance: 13 people, 22.41%
  9. Hypoaesthesia (reduced sense of touch or sensation): 12 people, 20.69%
  10. Depression: 12 people, 20.69%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Cognitive disorder?

- Check whether Cognitive disorder is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Cognitive disorder:

All the conditions that are associated with Cognitive disorder:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Cognitive disorder and Multiple sclerosis relapse, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: